Skip to content
Search
Please enter at least 3 characters.

Latest Stories

Keir Starmer commits to pharmacy expansion, sector demands urgent action on funding

Keir Starmer commits to pharmacy expansion, sector demands urgent action on funding

Sector leaders say community pharmacy can only reach their full potential if additional funding is provided and closures are stopped 

At Prime Minister’s Questions (PMQs) on Wednesday, Sir Keir Starmer highlighted his government's commitment to expanding the role of community pharmacy and independent prescribing to improve access to general practice.

He said: “We are going to expand the role of community pharmacies and accelerate the roll-out of independent prescribers. We need much more care to be delivered in local communities so that problems can be spotted earlier.”


The Prime Minister also talked about training more GPs and outlined the wider changes and improvements to the NHS that the government plans to deliver.

Janet Morrison, CEO of Community Pharmacy England (CPE) welcomed the government’s focus on community pharmacy.

She said: “We were very pleased to hear the Prime Minister talking so positively about community pharmacy at PMQs today, and we agree with him that community pharmacies hold the answer to improving access to wider primary care.”

However, Janet noted that these ambitions can only be achieved if “community pharmacies themselves are put on an economically sustainable footing.”

She said that CPE is actively engaged in discussions with ministers and looks forward to working with the government to achieve their shared goals for independent prescribing and enhancing the role of pharmacies in the healthcare system.

“We are ready to begin these discussions, and hope to do so very soon,” she added.

Paul Rees, chief executive of the National Pharmacy Association (NPA), echoed the need for urgent funding and action to prevent pharmacy closures.

Responding to the Prime Minister's comments at PMQs, Paul said: "It's good to see the government support the expansion of the role of community pharmacy and independent prescribing.

"However, pharmacies are also closing at a record rate, with seven a week closing so far this year and many more reducing their opening hours due to the impact of 40 per cent cuts.

"It is only with additional funding and an end to pharmacy closures that pharmacies can fulfil their full potential and take pressure away from overstretched GP's and hospital services."

During his speech at the 24th annual Pharmacy Business Awards, Pharmacy Minister Stephen Kinnock highlighted the crucial role that community pharmacies will play in the Labour government’s proposed healthcare reform.

He also acknowledged the financial strain faced by pharmacies and stated that the government is looking to address it as “a matter of urgency.”

More For You

Pharmacist Support calls for birthday donations to meet rising demand for mental health services

More and more pharmacy professionals are reaching out for help, said Danielle Hunt.

Pharmacist Support's birthday appeal: Donate to address growing mental health demand

Pharmacist Support – the independent charity dedicated to the pharmacy profession – is celebrating 184 years of service with the launch of a special birthday donations appeal.

On 15 April, the charity is urging individuals and organisations across the sector to support its campaign to raise vital funds to meet the increasing demand for its mental health and wellbeing services.

Keep ReadingShow less
Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less
RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less
NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less